Quarterly report pursuant to sections 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v2.4.0.6
Condensed Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues:        
Related party license revenues $ 650,000 $ 650,000 $ 1,950,000 $ 1,950,000
Service revenues 163,381   414,115  
Product revenues 318,447 504,902 831,472 703,983
Total revenues 1,131,828 1,154,902 3,195,587 2,653,983
Costs and operating expenses:        
Cost of product revenues 133,371 308,020 391,797 421,357
Research and development:        
Research and development costs 573,562 909,910 1,749,253 3,133,635
Reversal of R&D obligation (see Note 9)     (882,537)  
Selling, general, and administrative 1,441,934 1,367,644 4,585,082 3,709,120
Total costs and operating expenses 2,148,867 2,585,574 5,843,595 7,264,112
Operating loss (1,017,039) (1,430,672) (2,648,008) (4,610,129)
Other income (expense):        
Other income (expense), net 21,112 480 (3,513) (2,431)
Interest income 7,200 425 10,180 3,218
Interest expense (85,828) (705,839) (2,507,582) (1,846,164)
Net loss $ (1,074,555) $ (2,135,606) $ (5,148,923) $ (6,455,506)
Net loss per share attributable to common stockholders:        
Basic and diluted (in Dollars per share) $ (0.02) $ (0.13) $ (0.14) $ (0.41)
Weighted average shares outstanding:        
Basic and diluted (in Shares) 47,531,093 16,041,240 37,807,188 15,919,249